Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shulman

Showing results (131-140 of 759) with videos related to

Pageof 76
Sort By:
Carbohydrate Research|April 1, 1974
The synthesis of diastereomeric epoxy-(beta-D-glucopyranosyl)ethanes and 1,2-epoxy-3-(beta-D-glucopyranosyl)propanes, as irreversible inhibitors of beta-D-glucosidaseM I Shulman, S D Shiyan, A Y Khorlin
European Journal of Endocrinology|October 28, 2020
Recombinant human parathyroid hormone (1-84) is effective in CASR-associated hypoparathyroidismColin Patrick Hawkes, Dorothy I Shulman, Michael A Levine
The Journal of Clinical Investigation|April 1, 1992
31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitusD L Rothman, R G Shulman, G I Shulman
Biochemical Society Transactions|November 1, 1991
N.m.r. studies of muscle glycogen synthesis in normal and non-insulin-dependent diabetic subjectsD L Rothman, R G Shulman, G I Shulman
Diabetologia|March 11, 2016
Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosisRachel J Perry, Kitt Falk Petersen, Gerald I Shulman
Lancet (London, England)|July 9, 2010
Lipid-induced insulin resistance: unravelling the mechanismVarman T Samuel, Kitt Falk Petersen, Gerald I Shulman
Acta Endocrinologica|September 1, 1987
Age-related differences in the growth hormone secretory response to hGHRH 1-44 in male rats from infancy through puberty. In vivo and in vitro studiesD I Shulman, M Sweetland, G Duckett, et al.
Journal of Clinical Psychopharmacology|December 1, 1989
Dietary restriction, tyramine, and the use of monoamine oxidase inhibitorsK I Shulman, S E Walker, S MacKenzie, et al.
Metabolism: Clinical and Experimental|October 1, 1991
The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker ratsL Bowen, P P Stein, R Stevenson, et al.
Cell|March 16, 2004
Structural determinants of allosteric ligand activation in RXR heterodimersAndrew I Shulman, Christopher Larson, David J Mangelsdorf, et al.
Pageof 76

Showing results (131-140 of 759) with videos related to

Sort By:
Pageof 76
Carbohydrate Research|April 1, 1974
The synthesis of diastereomeric epoxy-(beta-D-glucopyranosyl)ethanes and 1,2-epoxy-3-(beta-D-glucopyranosyl)propanes, as irreversible inhibitors of beta-D-glucosidaseM I Shulman, S D Shiyan, A Y Khorlin
European Journal of Endocrinology|October 28, 2020
Recombinant human parathyroid hormone (1-84) is effective in CASR-associated hypoparathyroidismColin Patrick Hawkes, Dorothy I Shulman, Michael A Levine
The Journal of Clinical Investigation|April 1, 1992
31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitusD L Rothman, R G Shulman, G I Shulman
Biochemical Society Transactions|November 1, 1991
N.m.r. studies of muscle glycogen synthesis in normal and non-insulin-dependent diabetic subjectsD L Rothman, R G Shulman, G I Shulman
Diabetologia|March 11, 2016
Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosisRachel J Perry, Kitt Falk Petersen, Gerald I Shulman
Lancet (London, England)|July 9, 2010
Lipid-induced insulin resistance: unravelling the mechanismVarman T Samuel, Kitt Falk Petersen, Gerald I Shulman
Acta Endocrinologica|September 1, 1987
Age-related differences in the growth hormone secretory response to hGHRH 1-44 in male rats from infancy through puberty. In vivo and in vitro studiesD I Shulman, M Sweetland, G Duckett, et al.
Journal of Clinical Psychopharmacology|December 1, 1989
Dietary restriction, tyramine, and the use of monoamine oxidase inhibitorsK I Shulman, S E Walker, S MacKenzie, et al.
Metabolism: Clinical and Experimental|October 1, 1991
The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker ratsL Bowen, P P Stein, R Stevenson, et al.
Cell|March 16, 2004
Structural determinants of allosteric ligand activation in RXR heterodimersAndrew I Shulman, Christopher Larson, David J Mangelsdorf, et al.
Pageof 76